- Lenvatinib and pembrolizumab versus platinum doublet chemotherapy as second-line therapy for advanced or recurrent endometrial cancer
-
Yoneoka Y, Amano T, Takahashi A, Nishimura H, Deguchi M, Yamanaka H, Tanaka Y, Tsuji S, Murakami T
- KMID: 2561016
- Obstet Gynecol Sci.
- 2024 Nov;67(6):534-540.
- doi: 10.5468/ogs.24075
Objective There is no consensus on whether platinum doublet chemotherapy or lenvatinib and pembrolizumab (LEN/PEM) is superior for advanced or recurrent endometrial cancer. Thus, this study aimed to compare the... -
- CITED
-
- Close
- SHARE
-
- Close
- Possible Prevention of Neonatal Death: A Regional Population-Based Study in Japan
-
Koshida S, Yanagi T, Ono T, Tsuji S, Takahashi
- KMID: 2374049
- Yonsei Med J.
- 2016 Mar;57(2):426-429.
- doi: 10.3349/ymj.2016.57.2.426
PURPOSE: The neonatal mortality rate in Japan has currently been at the lowest level in the world. However, it is unclear whether there are still some potentially preventable neonatal deaths.... -
- CITED
-
- Close
- SHARE
-
- Close
- Nine Hereditary Movement Disorders First Described in Asia: Their History and Evolution
-
Jagota P, Ugawa Y, Aldaajani Z, Ibrahim NM, Ishiura H, Nomura Y, Tsuji S, Diesta C, Hattori N, Onodera O, Bohlega S, Al-Din A, Lim SY, Lee JY, Jeon B, Pal PK, Shang H, Fujioka S, Kukkle PL, Phokaewvarangkul O, Lin CH, Shambetova C, Bhidayasiri R
- KMID: 2545921
- J Mov Disord.
- 2023 Sep;16(3):231-247.
- doi: 10.14802/jmd.23065
Clinical case studies and reporting are important to the discovery of new disorders and the advancement of medical sciences. Both clinicians and basic scientists play equally important roles leading to... -
- CITED
-
- Close
- SHARE
-
- Close
